These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32790086)

  • 1. Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2.
    Fiore JR; Centra M; De Carlo A; Granato T; Rosa A; Sarno M; De Feo L; Di Stefano M; Errico M; Caputo SL; De Nittis R; Arena F; Corso G; Margaglione M; Santantonio TA
    J Med Virol; 2021 Mar; 93(3):1739-1742. PubMed ID: 32790086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy.
    Di Stefano M; Sarno M; Faleo G; Farhan Mohamed AM; Lipsi MR; De Nittis R; Bruno SR; De Feo L; Granato T; Corso G; Arena F; Centra M; Lo Caputo S; Margaglione M; Santantonio TA; Fiore JR
    Acta Haematol; 2021; 144(5):580-584. PubMed ID: 33878755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
    Gozlan Y; Reingold S; Koren R; Halpern O; Regev-Yochay G; Cohen C; Biber A; Picard O; Mendelson E; Lustig Y; Mor O
    Epidemiol Infect; 2021 Jun; 149():e153. PubMed ID: 34372950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased SARS-CoV-2 seroprevalence in healthy blood donors after the second pandemic wave in South-Eastern Italy: evidence for asymptomatic young donors as potential virus spreaders.
    Antonucci F; Fiore JR; De Feo L; Granato T; Di Stefano M; Faleo G; Farhan AM; Margaglione M; Centra M; Santantonio TA
    Infect Dis (Lond); 2022 Apr; 54(4):241-246. PubMed ID: 34781812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
    PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
    Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL
    PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
    Woudenberg T; Pelleau S; Anna F; Attia M; Donnadieu F; Gravet A; Lohmann C; Seraphin H; Guiheneuf R; Delamare C; Stefic K; Marlet J; Brochot E; Castelain S; Augereau O; Sibilia J; Dubos F; Meddour D; Guen CG; Coste-Burel M; Imbert-Marcille BM; Chauvire-Drouard A; Schweitzer C; Gatin A; Lomazzi S; Joulié A; Haas H; Cantais A; Bertholon F; Chinazzo-Vigouroux MF; Abdallah MS; Arowas L; Charneau P; Hoen B; Demeret C; Werf SV; Fontanet A; White M
    EBioMedicine; 2021 Aug; 70():103495. PubMed ID: 34304047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
    Borrega R; Nelson DKS; Koval AP; Bond NG; Heinrich ML; Rowland MM; Lathigra R; Bush DJ; Aimukanova I; Phinney WN; Koval SA; Hoffmann AR; Smither AR; Bell-Kareem AR; Melnik LI; Genemaras KJ; Chao K; Snarski P; Melton AB; Harrell JE; Smira AA; Elliott DH; Rouelle JA; Sabino-Santos G; Drouin AC; Momoh M; Sandi JD; Goba A; Samuels RJ; Kanneh L; Gbakie M; Branco ZL; Shaffer JG; Schieffelin JS; Robinson JE; Fusco DN; Sabeti PC; Andersen KG; Grant DS; Boisen ML; Branco LM; Garry RF
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
    Vignesh R; Shankar EM; Velu V; Thyagarajan SP
    Front Immunol; 2020; 11():586781. PubMed ID: 33101320
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
    Mveang Nzoghe A; Leboueny M; Kuissi Kamgaing E; Maloupazoa Siawaya AC; Bongho EC; Mvoundza Ndjindji O; Padzys GS; Ndeboko B; Ategbo S; Djoba Siawaya JF
    BMC Res Notes; 2021 Apr; 14(1):152. PubMed ID: 33879229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.
    Zaidi S; Rizwan F; Riaz Q; Siddiqui A; Khawaja S; Imam M; Naz A; Waheed S; Shamsi T
    J Public Health (Oxf); 2021 Apr; 43(1):3-8. PubMed ID: 32940328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.
    Edlow AG; Li JZ; Collier AY; Atyeo C; James KE; Boatin AA; Gray KJ; Bordt EA; Shook LL; Yonker LM; Fasano A; Diouf K; Croul N; Devane S; Yockey LJ; Lima R; Shui J; Matute JD; Lerou PH; Akinwunmi BO; Schmidt A; Feldman J; Hauser BM; Caradonna TM; De la Flor D; D'Avino P; Regan J; Corry H; Coxen K; Fajnzylber J; Pepin D; Seaman MS; Barouch DH; Walker BD; Yu XG; Kaimal AJ; Roberts DJ; Alter G
    JAMA Netw Open; 2020 Dec; 3(12):e2030455. PubMed ID: 33351086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
    Veldhoen M; Simas JP
    Nat Rev Immunol; 2021 Mar; 21(3):131-132. PubMed ID: 33402727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity.
    Balzan M
    Med Hypotheses; 2020 Oct; 143():110121. PubMed ID: 32759006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
    Chun JY; Jeong H; Kim Y
    J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.